Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Antiviral Chemistry & Chemotherapy
|
August 30, 2008
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition)
Hugh J Field
Expert Opinion on Therapeutic Targets
|
September 19, 2013
A short commentary on the review by Weller and Kuchta: the DNA helicase-primase complex as a target for herpes virus infection
Hugh J Field
Antiviral Chemistry & Chemotherapy
|
July 8, 2015
AVCC 1990-2015--A journal to combine antiviral biology and antiviral chemistry enters the third era
Hugh J Field
Antiviral Chemistry & Chemotherapy
|
July 10, 2008
Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations
Subhajit Biswas, Hugh J Field
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 25, 2010
Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus
Hugh J Field, Subhajit Biswas
Advances in Experimental Medicine and Biology
|
November 20, 2012
The helicase-primase complex as a target for effective herpesvirus antivirals
Hugh J Field, Ian Mickleburgh
Antiviral Chemistry & Chemotherapy
|
August 30, 2008
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses
Hugh J Field, Erik De Clercq
Antiviral Chemistry & Chemotherapy
|
August 30, 2008
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses
Erik De Clercq, Hugh J Field
The Journal of General Virology
|
September 20, 2000
The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment
Alana M Thackray, Hugh J Field
British Journal of Pharmacology
|
November 15, 2005
Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy
Erik De Clercq, Hugh J Field
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Antiviral Chemistry & Chemotherapy
|
August 30, 2008
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition)
Hugh J Field
Expert Opinion on Therapeutic Targets
|
September 19, 2013
A short commentary on the review by Weller and Kuchta: the DNA helicase-primase complex as a target for herpes virus infection
Hugh J Field
Antiviral Chemistry & Chemotherapy
|
July 8, 2015
AVCC 1990-2015--A journal to combine antiviral biology and antiviral chemistry enters the third era
Hugh J Field
Antiviral Chemistry & Chemotherapy
|
July 10, 2008
Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations
Subhajit Biswas, Hugh J Field
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 25, 2010
Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus
Hugh J Field, Subhajit Biswas
Advances in Experimental Medicine and Biology
|
November 20, 2012
The helicase-primase complex as a target for effective herpesvirus antivirals
Hugh J Field, Ian Mickleburgh
Antiviral Chemistry & Chemotherapy
|
August 30, 2008
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses
Hugh J Field, Erik De Clercq
Antiviral Chemistry & Chemotherapy
|
August 30, 2008
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses
Erik De Clercq, Hugh J Field
The Journal of General Virology
|
September 20, 2000
The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment
Alana M Thackray, Hugh J Field
British Journal of Pharmacology
|
November 15, 2005
Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy
Erik De Clercq, Hugh J Field
Page
of 4